Bioceltix S.A. Logo

Bioceltix S.A.

Developing 'off-the-shelf' stem cell therapies for diseases in companion animals.

BCX | WAR

Overview

Corporate Details

ISIN(s):
PLBCLTX00019 (+1 more)
LEI:
259400QZD5JYK8SLZU51
Country:
Poland
Address:
Wrocław Bierutowska 57-59/BUD.III, 51-317 Wrocław
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bioceltix S.A. is a biotechnology company specializing in the development of innovative biological medicines for the veterinary sector. The company focuses on creating 'off-the-shelf' biopharmaceuticals derived from mesenchymal stem cells for the treatment of diseases in companion animals. Utilizing its proprietary, scalable ALLO-BCLX technology, Bioceltix develops allogeneic stem cell therapies targeting common conditions, including degenerative joint disease in dogs and cats. The company's operations span from research and development to establishing manufacturing capabilities for its advanced veterinary therapeutics.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Bioceltix S.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-05-07 18:29
Declaration of Voting Results & Voting Rights Announcements
Informacja o liczbie akcji i głosów
Polish 74.3 KB
2024-05-07 18:29
Governance Information
Klauzula informacyjna o przetwarzaniu danych osobowych
Polish 174.2 KB
2024-05-07 18:29
Proxy Solicitation & Information Statement
Formularz głosowania przez pełnomocnika
Polish 160.9 KB
2024-05-07 18:29
Proxy Solicitation & Information Statement
Formularze pełnomocnictwa
Polish 115.1 KB
2024-05-07 18:29
Registration Form
Zestawienie zmian statutu
Polish 86.8 KB
2024-05-07 18:29
Share Issue/Capital Change
Opinia Zarządu
Polish 73.1 KB
2024-05-07 18:29
Post-Annual General Meeting Information
Projekty uchwał wraz z uzasadnieniem
Polish 148.9 KB
2024-05-07 18:29
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu NWZ
Polish 145.2 KB
2024-05-07 18:29
Pre-Annual General Meeting Information
Zwołanie NWZ na dzień 3 czerwca 2024 roku - Content (PL)
Polish 2.1 KB
2024-05-07 17:38
Share Issue/Capital Change
Przyjęcie planu budowy wielkoskalowej wytwórni komórek macierzystych i sposobu …
Polish 5.4 KB
2024-04-26 17:12
Annual / Quarterly Financial Statement
Podpisy do opinii biegłego rewidenta z badania Sprawozdania Finansowego Biocelt…
Polish 10.3 KB
2024-04-26 17:12
Annual / Quarterly Financial Statement
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za …
Polish 2.9 MB
2024-04-26 17:12
Annual / Quarterly Financial Statement
Podpisy do Raportu okresowego rocznego Bioceltix S.A. za rok 2023
Polish 20.9 KB
2024-04-26 17:12
Annual Report
Raport okresowy roczny Bioceltix S.A. za rok 2023
Polish 17.3 MB
2024-04-26 17:12
Annual Report
Podpisy do Sprawozdania z Działalności Bioceltix S.A. za okres sprawozdawczy za…
Polish 20.9 KB

Automate Your Workflow. Get a real-time feed of all Bioceltix S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bioceltix S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Antibiotice S.A. Logo
Manufactures FDA-approved generic drugs, sterile injectables, and APIs for global markets.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
Japan 4886
Astellas Pharma Inc. Logo Japan 4503
AstraZeneca PLC Logo
A global biopharma firm developing medicines for oncology, rare diseases, and biopharmaceuticals.
United Kingdom AZN
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland BANB

Talk to a Data Expert

Have a question? We'll get back to you promptly.